Integrated Biomarker And Imaging Study - 2

Clinical trial NCT00268996 · COMPLETED

Trial details

NCT number: NCT00268996
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Atherosclerosis

Start date: 2005-11-10
Primary completion: 2007-08-28
Enrollment: 336

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.